NASDAQ: SNSE - Sensei Biotherapeutics, Inc.

Rentabilidade por seis meses: -20.96%
Setor: Healthcare

Cronograma de promoção Sensei Biotherapeutics, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Sensei Biotherapeutics, Inc., an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. Its Tumor Microenvironment Activated Biologics platform is designed to unleash the anti-tumor potential of T cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company's pipeline includes SNS-101, SNS-103, and SNS-102, monoclonal antibodies, which are in early development stages for the treatment of solid tumors.

mais detalhes
It has a collaboration with The University of Washington to conduct preclinical studies for its SNS-101 program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

EBITDA -0.0124
EV/EBITDA -1.28
IPO date 2021-02-04
ISIN US81728A1088
Industry Biotechnology
P/BV 1
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.senseibio.com
Цена ао 1.04
Число акций ао 0.02795 млрд
Alteração de preço por dia: +3.92% (0.4792)
Alteração de preço por semana: +10.69% (0.4499)
Alteração de preço por mês: -10.35% (0.5555)
Alteração de preço em 3 meses: -10.35% (0.5555)
Mudança de preço em seis meses: -20.96% (0.6301)
Mudança de preço por ano: -28.03% (0.692)
Mudança de preço em 3 anos: -91.31% (5.73)
Mudança de preço em 5 anos: 0% (0.498)
Mudança de preço em 10 anos: 0% (0.498)
Mudança de preço desde o início do ano: +9.67% (0.4541)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 0 0
P/BV 0.2886 10
P/E 0 0
EV/EBITDA -0.3268 0
Total: 3.75

Eficiência

Nome Significado Nota
ROA, % -45.85 0
ROE, % -52.55 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.1701 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 0 0
Rentabilidade Ebitda, % 169.24 10
Rentabilidade EPS, % -20.78 0
Total: 5.6
Mais detalhes

Instituições Volume Compartilhar, %
Newtyn Management, LLC 1572023 6.27
Vanguard Group Inc 573651 2.29
Renaissance Technologies, LLC 143508 0.57
Geode Capital Management, LLC 136318 0.54
Bridgeway Capital Management, Inc. 112900 0.45
Duquesne Family Office LLC 100000 0.4
Bank of America Corporation 90788 0.36
Millennium Management LLC 38295 0.15
Blackrock Inc. 34813 0.14
Northern Trust Corporation 26049 0.1



Supervisor Cargo Pagamento Ano de nascimento
Mr. John K. Celebi M.B.A. President, CEO & Director 882.28k 1972 (53 ano)
Dr. Edward Van der Horst Ph.D. Chief Scientific Officer 630.81k 1974 (51 ano)
Ms. Lora Pike Vice President of Investor Relations & Communications N/A
Mr. Christopher W. Gerry J.D. Senior VP, General Counsel & Secretary N/A
Ms. Stephanie Krebs M.B.A., M.S. Chief Business Officer N/A 1978 (47 anos)
Dr. Aaron Weitzman FACP, M.D., Ph.D. Chief Medical Officer N/A
Mr. Josiah Craver Senior VP of Finance, Principal Financial Officer & Principal Accounting Officer

Endereço: United States, Rockville. MD, 1405 Research Boulevard - abrir no Google Maps, abrir mapas Yandex
Site: https://www.senseibio.com